All data are based on the daily closing price as of July 15, 2025
s

Selvas AI

108860.KQ
10.37 USD
0.13
+1.27%

Overview

Last close
10.37 usd
Market cap
279.05M usd
52 week high
15.21 usd
52 week low
7.23 usd
Target price
5.82 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
3.4087
Price/Book Value
3.1716
Enterprise Value
203.80M usd
EV/Revenue
2.5177
EV/EBITDA
32.9535

Key financials

Revenue TTM
80.95M usd
Gross Profit TTM
42.67M usd
EBITDA TTM
6.59M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
214.19M usd
Net debt
N/A usd

About

Selvas AI Inc. operates as an artificial intelligence (AI) company in South Korea. The company offers Selvy Note, an AI Voice Record for recognizing the content of conversations such as research, consultation, and meetings; Selvy MediVoice, an AI medical voice recognition that generates medical records during the medical process through voice; Selvy SpeechEdu, an AI training voice recognition for text utilization learning, sentence pronunciation accuracy learning, and sophisticated pronunciation at the phoneme/phonetic level. It also provides odiro, an AI voice content creation solution; Selvy Alrimi, an AI announcement solution to enter the broadcast content as text and the announcement voice can be automatically transmitted at the desired time; Selvy Checkup, an AI disease occurrence probability prediction solution; OnFit, an IoT-based smart fitness/fitness membership management program; Selpub, a cloud-based multimedia eBook; and DIODICT, a mobile electronic dictionary. The company was formerly known as DIOTEK Co., Ltd. and changed its name to Selvas AI Inc. in September 2016. Selvas AI Inc. was founded in 1999 and is based in Seoul, South Korea.
  • Symbol
    108860.KQ
  • Exchange
    KQ
  • Isin
    KR7108860008
  • Country
    South Korea
  • Sector
    Technology
  • Industry
    Software - Application
  • CEO
    Jeong-In Doh
  • Headquarter
    Seoul
  • Web site
    https://www.selvasai.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top